Uncovering a Novel Molecular Therapeutic Target for HIV-Associated Neurocognitive Impairment
Johns Hopkins Medicine via YouTube
Learn Backend Development Part-Time, Online
Build with Azure OpenAI, Copilot Studio & Agentic Frameworks — Microsoft Certified
Overview
AI, Data Science & Cloud Certificates from Google, IBM & Meta — 40% Off
One plan covers every Professional Certificate on Coursera. 40% off Coursera Plus Annual.
Unlock All Certificates
Join a seminar from the Joint NIMH Center Series featuring Dr. Reina Bendayan from the University of Toronto as she explores groundbreaking research on molecular therapeutic targets for HIV-Associated Neurocognitive Impairment. Discover the latest findings in neuroHIV research and potential treatment approaches during this hour-long presentation from Johns Hopkins Medicine. Learn about innovative pharmaceutical developments and therapeutic strategies aimed at addressing cognitive impairments in HIV patients. Gain insights from Dr. Bendayan's expertise as a distinguished pharmacologist and fellow of multiple prestigious academic societies (FAAPS, FCSPS, FCAHS) while exploring the intersection of HIV treatment and neurocognitive health.
Syllabus
Uncovering a Novel Molecular Therapeutic Target for HIV-Associated Neurocognitive Impairment
Taught by
Johns Hopkins Medicine